Table 2.
Verified 7-Day Point Prevalence and Continuous Abstinence Rates
Assessment timepoint | 7-day point prevalence | Continuous abstinence | ||||
---|---|---|---|---|---|---|
AE (n = 30) | HEC (n = 31) | OR (95% CI) | AE (n = 30) | HEC (n = 31) | OR (95% CI) | |
End of treatment (8 weeks postquit date) | 40.0% | 22.6% | 2.28 (0.75, 6.96) | 30.0% | 25.8% | 1.23 (0.4, 3.78) |
6-month follow-up (21 weeks postquit date) | 26.7% | 12.9% | 2.46 (0.65, 9.26) | 23.3% | 9.7% | 2.83 (0.66, 12.18) |
12-month follow-up (47 weeks postquit date) | 26.7% | 12.9% | 2.46 (0.65, 9.26) | 13.3% | 3.2% | 4.64 (0.48, 44.5) |
Note. AE = aerobic exercise; HEC = health education control; OR = odds ratio; CI = confidence interval.